<span>Well, the
two layers of skin are very important because they help protect and preserve
your insides of your body. The top layer of your skin, your Epidermis, is important because it
contains melanin to keep your skin from burning (sunburn) and also protects it from
harmful UV and sun radiation. It also has a protective layer that acts as a
barrier to keep water or other fluids, bacteria, and other foreign objects out
of your body. The second layer of your skin, your Dermis is the thickest layer of skin that protects you in a few
different ways. It contains sweat glands that automatically excrete sweat when
your body gets warm. It is a way for your body to naturally cool itself down
and regulate its temperature. This layer of skin also contains sensory nerves
that send signals to the brain whenever someone touches your arm or when you
get hurt. Without those nerves, if you had an injury or burn that is deeper
than the first layer of skin, you may not be able to feel it.</span>
No cap that baby got me shivering in my boots
Answer:
It would not be advisable to promote a product before they approve it since you do not know if they will validate it and you will spend on marketing for pleasure
Whether or not a new drug requires approval The FDA's dependence on the new drug fits an over-the-counter (OTC) monograph. OTC monographs specified conditions under which the FDA has predetermined that a medication will be safe and effective. Once an OTC monograph is finalized, medication devices can market OTC medications that conform to the monograph without FDA approval. The FDA also uses the application at its discretion to allow certain medications to be marketed without approval if they conform to tentative final monographs.
If a new medication does not meet a monograph, it will require FDA approval. To obtain FDA approval, drug manufacturers must conduct laboratory tests, animal and human clinical analyzes, and submit their information to FDA. The FDA will review the information and may then approve the medication if the agency determines the benefits of the medication plus the risks to the intended use. Marketing a new drug that is not compliant with an OTC monograph and without an FDA test is considered as marketing a new unapproved medication, which is a prohibited act under the Food, Drug and Cosmetic Act (FD&C Act).